abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2017年6月27日

作者:
German Lopez, Vox (USA)

USA: Opioids deaths lead state officials to target drug firms, following model of lawsuits against tobacco industry

"US officials are starting to treat opioid companies like Big Tobacco — and suing them", 7 Jun 2017

…This year, multiple lawsuits have been launched against opioid manufacturers and distributors.  With the opioid crisis now having resulted in more than 300,000 deadly opioid overdoses since 1999...there’s a push to hold accountable the people and companies behind the products…These lawsuits get to the two major legal arguments that different jurisdictions are raising against opioid makers and distributors:

1. Starting in the mid-1990s, opioid manufacturers unleashed a misleading marketing push underplaying the risks of prescription opioids and exaggerating the drugs’ proven benefits. This, the lawsuits argue, adds up to false advertising with deadly consequences — by encouraging doctors to overprescribe the pills and getting patients to think the pills were safe and effective.

2. Opioid distributors supplied a ton of these pills, even when they should have known they were going to people who were misusing the drugs...

Opioid manufacturers and distributors, of course, ferociously deny these allegations...

Purdue [Pharma] gave a comment...: “We share the...concerns about the opioid crisis and we are committed to working collaboratively to find solutions...[W]e are an industry leader in the development of abuse-deterrent technology, advocating for the use of prescription drug monitoring programs and supporting access to Naloxone [medication to block the effects of opioids] — all important components for combating the opioid crisis.”

[refers to Allergan, AmerisourceBergen, Cardinal Health, Cephalon (part of Teva Pharmaceutical Industries), CVS, Endo, Janssen Pharmaceuticals (part of Johnson & Johnson), Johnson & Johnson, Mallinckrodt Pharmaceuticals, McKesson, Teva Pharmaceutical Industries, Walgreen, Walmart]

 

時間線

隱私資訊

本網站使用 cookie 和其他網絡存儲技術。您可以在下方設置您的隱私選項。您所作的更改將立即生效。

有關我們使用網絡儲存技術的更多資訊,請參閱我們的 數據使用和 Cookie 政策

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

分析cookie

ON
OFF

您瀏覽本網頁時我們將以Google Analytics收集信息。接受此cookie將有助我們理解您的瀏覽資訊,並協助我們改善呈現資訊的方法。所有分析資訊都以匿名方式收集,我們並不能用相關資訊得到您的個人信息。谷歌在所有主要瀏覽器中都提供退出Google Analytics的添加應用程式。

市場營銷cookies

ON
OFF

我們從第三方網站獲得企業責任資訊,當中包括社交媒體和搜尋引擎。這些cookie協助我們理解相關瀏覽數據。

您在此網站上的隱私選項

本網站使用 cookie 和其他網絡儲存技術來增強您在必要核心功能之外的體驗。